Xin Xin

Xin Xin has a diverse work experience spanning several companies and roles. In 2014, Xin worked as a Co-op at Genentech. From 2015 to 2016, Xin held internships at Bai Shi Mei Sheng Bao and CCG Life Sciences. Xin then joined The Ohio State University as a Research Associate from 2012 to 2017. In 2017, Xin became a Scientist in Biologics CMC at Teva Pharmaceuticals until 2019. From 2019 to 2020, Xin worked as a Senior Scientist at WuXi Advanced Therapies. Xin then transitioned to the role of Associate Principal Scientist I, Group Leader from 2020 to 2021, and later became an Associate Principal Scientist II until 2022. Xin also served as an EC member and co-chair of the venture forum team at SAPA-GP from 2019. Currently, Xin holds the position of Senior Director of upstream PD and Manufacture at Exegenesis Bio from 2021.

Xin Xin completed a Bachelor of Engineering degree in Biopharmaceutical Engineering at Jiangnan University from 2007 to 2011. Subsequently, Xin pursued a Doctor of Philosophy (Ph.D.) in Chemical and Biomolecular Engineering at The Ohio State University, which was completed between 2012 and 2017.